Advertisement

Picture Demy-Colton BioFuture 2024 NYC 3 Biotech Breakthroughs 650x100px

News > All

Total search results: 6340 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 62 63 64

order ascendingorder descendingSource order ascendingorder descendingDate
Keros Therapeutics, Inc.. (1/7/19). "Press Release: Keros Therapeutics Receives $23 Million Series B Funding for Development of Therapies to Treat Debilitating Neuromuscular Diseases". Lexington, MA. 2019-01-07
BioMed X GmbH. (1/7/19). "Press Release: Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology". Heidelberg. 2019-01-07
Aptamer Group Ltd.. (1/7/19). "Press Release: Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices". 2019-01-07
Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA. 2019-01-07
Galapagos N.V.. (1/7/19). "Press Release: Galapagos Starts First Phase 1 Trial with Toledo Compound". Mechelen. 2019-01-07
Foundation Medicine, Inc.. (1/7/19). "Press Release: Foundation Medicine Announces Executive Leadership Transition". Cambridge, MA. 2019-01-07
Galapagos N.V.. (1/6/19). "Press Release: Galapagos Initiates NOVESA Phase 2a Trial in Patients with Systemic Sclerosis". Mechelen. 2019-01-06
Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. 2019-01-04
CRISPR Therapeutics AG. (1/4/19). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease". Zug, Cambridge, MA & Boston, MA. 2019-01-04
Immunocore Ltd.. (1/4/19). "Press Release: Immunocore Appoints Bahija Jallal as Chief Executive Officer". Oxford & Conshohocken, PA. 2019-01-04
Ribon Therapeutics, Inc.. (1/4/19). "Press Release: Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer". Lexington, MA. 2019-01-04
Oculis S.A.. (1/4/19). "Press Release: Oculis Raises CHF15.5 Million in an Extension of Its Series B Financing Round – Total Raised CHF35.5 Million". Lausanne. 2019-01-04
Oculis S.A.. (1/4/19). "Press Release: Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF alpha Antibody Fragment". Lausanne. 2019-01-04
Boehringer Ingelheim. (1/4/19). "Press Release: Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna". Ingelheim & Cambridge, MA. 2019-01-04
Medigene AG. (1/4/19). "Press Release: Medigene Licenses Co-stimulator to Enhance TCR Therapies for Solid Tumors". Planegg. 2019-01-04
BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. 2019-01-04
BioNTech AG. (1/4/19). "Press Release: BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and Appoints Dr. Ulrich Wandschneider as Member of Supervisory Board". 2019-01-04
Galapagos N.V.. (1/4/19). "Press Release: Fibrocor and Galapagos Sign Partnership in Fibrosis". Mechelen. 2019-01-04
ADC Therapeutics S.A.. (1/4/19). "Press Release: ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors". Lausanne. 2019-01-04
Leerink Partners LLC. (1/4/19). "Press Release: SVB Financial Group Completes Acquisition of Healthcare Investment Bank Leerink Partners". Santa Clara, CA. 2019-01-04
Kiadis Pharma N.V.. (1/4/19). "Press Release: Kiadis Pharma Expands Presence in the United States". Amsterdam & Boston, MA. 2019-01-04
Biogen Inc.. (1/4/19). "Press Release: Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets". Cambridge, MA & Waltham, MA. 2019-01-04
C4 Therapeutics, Inc.. (1/4/19). "Press Release: Roche Degrader-based Medicines Collaboration. C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-based Medicines with Roche". Watertown, MA. 2019-01-04
Rentschler Biopharma SE. (1/3/19). "Press Release: Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site". Laupheim & Milford, MA. 2019-01-03
UroGen Pharma Ltd.. (1/3/19). "Press Release: UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer". New York, NY. 2019-01-03
Bristol-Myers Squibb Company. (1/3/19). "Press Release: Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company". New York, NY & Summit, NJ. 2019-01-03
ProBioGen AG. (1/3/19). "Press Release: ProBioGen’s GlymaxX ADCC Enhancement Technology Used by Betta Pharmaceuticals". Berlin. 2019-01-03
Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen. 2019-01-03
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders". Nashville, TN & Ingelheim. 2019-01-03
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies". Ingelheim & Playa Vista, CA. 2019-01-03
Immatics Biotechnologies GmbH. (1/3/19). "Press Release: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies". Munich. 2019-01-03
Verily Life Sciences. (1/3/19). "Press Release: Verily Announces $1 Billion Investment Round to Fund Growth and Innovation". South San Francisco, CA. 2019-01-03
InflaRx N.V.. (1/3/19). "Press Release: InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management". Jena & New York, NY. 2019-01-03
ADC Therapeutics S.A.. (1/3/19). "Press Release: ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors". Lausanne. 2019-01-03
Confo Therapeutics N.V.. (1/3/19). "Press Release: Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology". Ghent. 2019-01-03
Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna. 2019-01-02
Bruker Corporation. (2/1/19). "Press Release: Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference". Billerica, MA. 2019-01-02
OBN (UK) Ltd.. (1/2/19). "Press Release: OBN Appoints New Chairman and Non-Executive Director to Enhance Board Expertise". Abingdon. 2019-01-02
MyoKardia, Inc.. (1/2/19). "Press Release: MyoKardia Regains Global Rights to Mavacamten and MYK-491 Programs from Sanofi". South San Francisco, CA. 2019-01-02
Promethera Biosciences S.A.. (1/2/19). "Press Release: Promethera Biosciences Announces Investment by Itochu Corporation and a Broad Strategic Collaboration to Access the Asian Markets". Mont-Saint-Guibert & Tokyo. 2019-01-02
next pagenext page 1 2 3 ... 62 63 64



Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top